DLPH, PIRS, and ARRY stocks are making notable moves on the charts today
Apple's earnings report is still holding back the Dow this afternoon. Among specific stocks on the move are car tech specialist Delphi Automotive PLC (NYSE:DLPH), as well as biotech stocks Pieris Pharmaceuticals Inc (NASDAQ:PIRS) and Array Biopharma Inc (NASDAQ:ARRY). Here's a quick look at what's moving shares of DLPH, PIRS, and ARRY.
Delphi Automotive Hits New High on Earnings, Spin-Off News
DLPH stock is the top percentage gainer on the S&P 500 Index (SPX), up 9.5% today at $85.94, and earlier touching an annual high of $88.35, thanks to an earnings beat. The company also said it plans to spin off its powertrain business. With today's move, Delphi Automotive PLC is up 27.6% in 2017, and analysts are certainly bullish. At the moment, 13 of the 16 covering brokerage firms say to buy DLPH stock.
AstraZeneca Deal Puts Pieris Near the Top of the Nasdaq
PIRS stock is soaring today, due to news of a $57.5 million deal with AstraZeneca plc (ADR) (NYSE:AZN) to develop drugs for respiratory issues. The stock is one of the top gainers on the Nasdaq at last check, up 54.6% at $3.71 -- bringing its year-to-date advance to 164%. Plenty of short sellers are getting burned, too. Short interest on Pieris Pharmaceuticals Inc jumped by 61% over the past two reporting periods.
Analyst Upgrade Helps Array Biopharma Shares Rebound
After taking a 16% hit yesterday, ARRY stock is bouncing back, thanks to an upgrade to "overweight" at J.P. Morgan Securities. The shares are now trading back atop their rising 200-day moving average, adding 6.6% today at $7.85. This is likely good news for options traders, who have shown bullish tendencies. For instance, Array Biopharma Inc has a 50-day call/put volume ratio of 40.39 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) , which ranks in the 91st annual percentile.